Diabetes Mellitus Associated with Clozapine Therapy
- 1 July 2000
- journal article
- case report
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 20 (7) , 844-847
- https://doi.org/10.1592/phco.20.9.844.35201
Abstract
Clozapine is an atypical antipsychotic that is associated with certain adverse effects that limit its usefulness. Published case reports have associated clozapine with impairment of glucose tolerance, including the onset or exacerbation of diabetes mellitus. We report two patients who experienced diabetes mellitus associated with the agent.Keywords
This publication has 17 references indexed in Scilit:
- Body-Mass Index and Mortality in a Prospective Cohort of U.S. AdultsNew England Journal of Medicine, 1999
- Clozapine-Induced Diabetic KetoacidosisAustralian & New Zealand Journal of Psychiatry, 1999
- The effect of clozapine on glucose metabolismExperimental and Clinical Endocrinology & Diabetes, 1998
- Clozapine and Associated Diabetes MellitusThe Journal of Clinical Psychiatry, 1997
- Differential effect of clozapine on weight: a controlled studyAmerican Journal of Psychiatry, 1996
- Ketoacidosis as a side‐effect of clozapine: a case reportActa Psychiatrica Scandinavica, 1996
- Diabetes mellitus in schizophrenic patientsComprehensive Psychiatry, 1996
- Weight Gain as a Risk Factor for Clinical Diabetes Mellitus in WomenAnnals of Internal Medicine, 1995
- Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptorsNature, 1995
- Effects of the 5-HT1C/5-HT2 receptor agonists DOI and α-methyl-5-HT on plasma glucose and insulin levels in the ratEuropean Journal of Pharmacology, 1990